Earli is searching for natural biomarkers of cancer to develop treatment devices. Early detection of cancer is important for identifying patients at risk before cancers spread and become more lethal. Earli is applying state-of-the-art techniques from synthetic biology to identify cancer cells using PET scans. Earli’s radically new technique forces cancer to produce a synthetic biomarker to reveal itself as opposed to searching for an endogenous one with a low signal to noise ratio. By using mouse and canine models, Earli is working fast to optimize and bring diagnostics to human patients. Earli’s approach has attracted an impressive Advisory Board including Nobel Laureates and the co-founder of Moderna.